Breaking News

FUJIFILM Cellular Dynamics Opens iPSC Facility

New Innovation Facility for Advanced Cell Therapy (i-FACT) will house development and manufacture of iPSCs for therapeutic applications

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Cellular Dynamics, Inc. (FCDI), a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, will begin operations at its new cGMP-compliant iPSC production facility in Madison, WI on March 4. The new Innovation Facility for Advanced Cell Therapy (i-FACT), will house development and manufacture of iPSCs for therapeutic applications. The i-FACT will enable FCDI to accelerate the development of its own pipeline of regenerative medicine therapies using i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters